Galantamine Hydrobromide
3 NDCs across 1 manufacturer|3 Generic,0 Brand
Galantamine Hydrobromide is used to treat alzheimer disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 28, 2001, and the first generic was approved Aug 28, 2008. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient.
Galantamine Hydrobromide is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $0.80 to $0.90 per EA — a 13% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
1
competing in market
Price Spread
$0.80 – $0.90
per EA
7d Activity
avg -2.9% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cholinesterase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GALANTAMINE HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GALANTAMINE ER 24 MG CAPSULE | $0.9050 per EA | -10.03% |
GALANTAMINE ER 16 MG CAPSULE | $0.8460 per EA | +0.22% |
GALANTAMINE ER 8 MG CAPSULE | $0.8024 per EA | +1.07% |
Frequently Asked Questions
What is Galantamine Hydrobromide used to treat?
Galantamine Hydrobromide is used to treat alzheimer disease, per the National Library of Medicine's MED-RT classification.
When did Galantamine Hydrobromide become available as a generic?
FDA approved the first generic Galantamine Hydrobromide (ANDA) on Aug 28, 2008. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Galantamine Hydrobromide products are on the market?
The Galantamine Hydrobromide drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.
What is the price range for Galantamine Hydrobromide?
NADAC reference prices for Galantamine Hydrobromide range from $0.8024 to $0.9050 per EA — a 13% difference between cheapest and most expensive.
Which manufacturers make Galantamine Hydrobromide?
1 manufacturer lists Galantamine Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (3).
How has the price of Galantamine Hydrobromide changed recently?
Over the past 7 days, 2 Galantamine Hydrobromide NDCs rose and 1 fell, with a market-wide average change of -2.9%.